Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. Recently published papers — a series of reviews, two human studies, and an animal study — only bolster the case that cannabis can help those suffering from this confounding condition.

THC 144

THC CBD Sleep Clinical Trials 144

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. Cannabis and Anxiety. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Kind Meds (Cannabis Education Blog)

OCTOBER 19, 2020

However, these treatments have not proven to be wholly effective in managing the symptoms of depression. For some individuals, conventional treatments only worsen the symptoms of depression. This has spurred significantly greater interest in alternative remedies, including using cannabis for mental health treatment.

Treatment 111

Treatment Research and Development Strains THC 111

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Epilepsy is a neurological condition, that directly affects the nervous system and causes seizures in individuals who suffer from the condition. CONVENTIONAL TREATMENT. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 188

Clinical Trials Chronic Pain Data Treatment 188

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

The Cannigma

FEBRUARY 1, 2023

Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies.

Access 98

Access Patients Chronic Pain Conditions 98

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

SpeedWeed

FEBRUARY 21, 2021

Previously, Kaminski and GB Sciences had collaborated on finding mixtures of cannabinoids that would reduce inflammation caused by viruses like HIV. “If If successful, data from (Kaminski’s) pre-clinical study would be used as part of the support for an Independent New Drug filing with the FDA,” said Small-Howard.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

Project CBD

JANUARY 24, 2019

In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment. Cannabis and ADHD.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

DECEMBER 20, 2021

Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects.

Data 52

Data Patients Access Wellness and Beauty 52

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Veriheal

MAY 18, 2023

Chronic pain —a condition that affects 50.2 Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. million people in the U.S. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! When your pet gets sick, you give up everything and try to find them the best possible medicine or treatment available. It mainly consists of two types of cannabinoid receptors (CB1 and CB2). Lets review some data. I do the exact same thing. CBD is a Powerful Painkiller.

Pets 45

Pets Data CBD Cannabinoids 45

The Cannigma

FEBRUARY 14, 2021

Both apps are technological tools for journaling, a technique that can be used by medical patients looking to treat specific symptoms or conditions, but also by recreational cannabis users trying to hone in on the products and delivery methods that will reliably produce the effects they’re looking for. What is cannabis journaling?

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

Veriheal

SEPTEMBER 16, 2022

Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. The team included 143 patients in their research and evaluated pain intensity through the use of a numeric pain scale from the baseline to 120 days post-treatment initiation.

Patients 120

Patients Chronic Pain Research and Development Treatment 120

Cannabis Law Report

NOVEMBER 12, 2021

Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

SEPTEMBER 29, 2021

The Cannabinoid Institute ?(TCI) The data revealed that clinicians who had never experienced cannabis firsthand viewed it much more negatively and stigmatized, whereas clinicians who had experience firsthand with cannabis understood the potential medical benefit for some clinical conditions,” noted Jan Roberts , Founder of TCI.

Cannabinoids 52

Cannabinoids Education Patients Safety 52

CannaMD

NOVEMBER 22, 2020

For those who suffer from migraine pain, the excruciating condition can be completely debilitating, impossible to manage without a dark room, a cool cloth over the eyes, and sublime silence. Patients used the app, Strainprint, which allowed data to be archived and studied. and migraine severity by 49.6%. Find Out if You Qualify.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122